December 13, 2017 2:32 AM ET

Healthcare Equipment and Supplies

Company Overview of Sorrento Tech, Inc.

Company Overview

Sorrento Tech, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single and integrated platform. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing...

20 Independence Boulevard

Warren, NJ 07059

United States

Founded in 2009

90 Employees

Phone:

908-605-4700

Key Executives for Sorrento Tech, Inc.

Chief Executive Officer, President, Secretary and Director
Age: 52
Total Annual Compensation: $454.3K
Founder and Chairman
Age: 61
Total Annual Compensation: $594.4K
Chief Financial Officer, Vice President and Treasurer
Age: 47
Total Annual Compensation: $294.8K
Compensation as of Fiscal Year 2016.

Sorrento Tech, Inc. Key Developments

Roka Bioscience, Inc. Approves Amendment to Restated Certificate of Incorporation

Roka Bioscience, Inc. at its special meeting held on October 26, 2017, approved amendment to the company’s restated certificate of incorporation to decrease the company’s authorized shares of common stock and authorized and undesignated shares of preferred stock.

Roka Bioscience, Inc. Proposes Amendment to Restated Certificate of Incorporation

Roka Bioscience, Inc. announced that at its special meeting of stockholders to be held on October 26, 2017 proposed to approve the amendment to the company’s Restated Certificate of Incorporation to decrease the company’s authorized shares of common stock and authorized and undesignated shares of preferred stock.

Roka Bioscience, Inc., Special/Extraordinary Shareholders Meeting, Oct 26, 2017

Roka Bioscience, Inc., Special/Extraordinary Shareholders Meeting, Oct 26, 2017, at 09:00 US Eastern Standard Time. Location: at the offices of Lowenstein Sandler LLP One Lowenstein Drive, Roseland New Jersey United States Agenda: To consider and vote on a proposal to adopt the asset purchase agreement, dated as of august 16, 2017, by and among the company and Rokabio, Inc; to approve the winding up and liquidation of the company pursuant to the terms of the plan of complete liquidation and dissolution of the company; approve the amendment to the company’s restated certificate of incorporation to decrease the company’s authorized shares of common stock and authorized and undesignated shares of preferred stock; and to approve the adjournment of the special meeting, if necessary, in the reasonable discretion of the chief executive officer and president of the company, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the asset sale proposal.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
August 17, 2017
Roka Bioscience, Inc., Substantially All Assets
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sorrento Tech, Inc., please visit www.rokabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.